|
|
|
|
| LEADER |
05075nam a2200553 4500 |
| 001 |
ocn891400095 |
| 003 |
OCoLC |
| 005 |
20180501122021.0 |
| 006 |
m o d |
| 007 |
cr cn||||||||| |
| 008 |
140822t20142014mauaf ob 001 0 eng d |
| 040 |
|
|
|a E7B
|b eng
|e rda
|e pn
|c E7B
|d OCLCO
|d UIU
|d OCLCF
|d EBLCP
|d YDXCP
|d N$T
|d OHS
|d DEBSZ
|d OCLCQ
|d FEM
|d OCLCQ
|d DGU
|d OCLCO
|d OCLCQ
|d OCLCA
|d GrThAP
|
| 019 |
|
|
|a 887508646
|a 968061260
|a 969042105
|
| 020 |
|
|
|a 9780128004395
|q (e-book)
|
| 020 |
|
|
|a 0128004398
|q (e-book)
|
| 020 |
|
|
|a 9780128002544
|
| 035 |
|
|
|a (OCoLC)891400095
|z (OCoLC)887508646
|z (OCoLC)968061260
|z (OCoLC)969042105
|
| 050 |
|
4 |
|a QP535.N1
|b .N587 2014eb
|
| 072 |
|
7 |
|a SCI
|x 008000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 572.54
|2 23
|
| 049 |
|
|
|a TEFA
|
| 245 |
0 |
0 |
|a Nitric oxide /
|c series editor, Gerald Litwack.
|
| 264 |
|
1 |
|a Waltham, Massachusetts :
|b Elsevier,
|c 2014.
|
| 264 |
|
4 |
|c ©2014
|
| 300 |
|
|
|a 1 online resource (483 pages, 32 unnumbered pages of plates) :
|b illustrations.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Vitamins And Hormones ;
|v Volume 96
|
| 504 |
|
|
|a Includes bibliographical references at the end of each chapters and index.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (ebrary, viewed August 22, 2014).
|
| 505 |
0 |
|
|a Front Cover; Nitric Oxide; Copyright; Former Editors; Contents; Contributors; Preface; Chapter One: Regulation of Nociceptive Transduction and Transmission by Nitric Oxide; 1. Introduction; 2. Role of NO in Nociceptive Transduction at the Periphery; 3. Diverse Effects of NO on Ion Channels Expressed on Primary Sensory Neurons; 3.1. Acid-sensing ion channels; 3.2. Transient receptor potential channels; 3.2.1. TRPV1; 3.2.2. TRPA1; 3.2.3. TRPV3 and TRPV4; 3.3. KATP channels; 4. Role of NO in Regulating Nociceptive Transmission at the Spinal Cord Level.
|
| 505 |
8 |
|
|a 5. NO Reduces Excitatory, But Potentiates Inhibitory, Synaptic Transmission in Spinal Cords5.1. Glutamatergic input from primary afferent nerves; 5.2. Voltage-activated calcium channels in sensory neurons; 5.3. Synaptic NMDA receptors; 5.4. Synaptic release of glycine; 6. Conclusions and Future Directions; Acknowledgments; References; Chapter Two: microRNA and Human Inducible Nitric Oxide Synthase; 1. Introduction; 2. Regulation of Human iNOS Gene; 2.1. Transcriptional; 2.2. Posttranscriptional; 3. miRNAs Regulation; 3.1. miR-939; 3.2. other miRNAs; 4. Conclusion; References.
|
| 505 |
8 |
|
|a Chapter Three: Heart Mitochondrial Nitric Oxide Synthase: A Strategic Enzyme in the Regulation of Cellular Bioenergetics1. Introduction; 2. Heart Mitochondrial NO Production; 2.1. Heart mtNOS activity; 2.2. Heart mtNOS identity; 3. Regulation of Heart mtNOS; 3.1. Effect of substrates and cofactors; 3.2. Effect of mitochondrial metabolic state and membrane potential; 4. Effects of NO on Heart Mitochondrial Function; 4.1. Nitric oxide consumption reactions in mitochondria; 4.2. Regulation of mitochondrial function by NO; 4.3. Mitochondrial NOS functional activity.
|
| 505 |
8 |
|
|a 5. Physiopathological Regulation of Heart mtNOS5.1. Heart chronic hypoxia; 5.2. Heart acute hypoxia and ischemia-reperfusion; 6. Conclusions and Future Directions; Acknowledgments; References; Chapter Four: Nitric Oxide Regulation of Adult Neurogenesis; 1. Introduction; 2. Adult Neurogenesis; 3. Expression of NOS in Neurogenic Regions; 4. Pharmacological Studies of NO on Adult Neurogenesis In Vivo; 5. NOS Knockout Animals and Adult Neurogenesis; 6. Neuropeptide Y and NO; 7. The Dual Role of NO in Adult Neurogenesis; 8. Concentration-Dependent Effects of NO; 9. Conclusions; References.
|
| 505 |
8 |
|
|a Chapter Five: Nitric Oxide in the Nervous System: Biochemical, Developmental, and Neurobiological Aspects1. Introduction; 1.1. Brief history and biochemistry of NOS; 1.2. NO classical actions; 1.3. Interesting partners in the CNS: Focusing on NMDA receptors; 2. NO Signaling Pathways; 2.1. PKG modulation by NO; 2.2. AKT modulation by NO; 2.3. ERK1/2 modulation by NO; 2.4. Src modulation by NO; 2.5. CREB modulation by NO; 3. NO and Neuronal Viability; 4. NO and Neurotransmitters Release; 4.1. Glutamate release; 4.2. GABA release; 4.3. DA release; 4.4. 5-Hydroxytryptamine release.
|
| 650 |
|
0 |
|a Nitric oxide
|x Physiological effect.
|
| 650 |
|
0 |
|a Nitric oxide.
|
| 650 |
|
0 |
|a Nitrous oxide.
|
| 650 |
|
2 |
|a Nitric Oxide.
|0 (DNLM)D009569
|
| 650 |
|
7 |
|a SCIENCE
|x Life Sciences
|x Biology.
|2 bisacsh
|
| 650 |
|
7 |
|a Nitric oxide.
|2 fast
|0 (OCoLC)fst01037984
|
| 650 |
|
7 |
|a Nitric oxide
|x Physiological effect.
|2 fast
|0 (OCoLC)fst01037990
|
| 650 |
|
7 |
|a Nitrous oxide.
|2 fast
|0 (OCoLC)fst01038177
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Gerald, Litwack,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Nitric oxide.
|d Waltham, Massachusetts : Elsevier, ©2014
|h xviii, 436 pages
|k Vitamins and hormones ; Volume 96
|z 9780128002544
|
| 830 |
|
0 |
|a Vitamins and hormones ;
|v Volume 96.
|
| 856 |
4 |
0 |
|u https://www.sciencedirect.com/science/bookseries/00836729/96
|z Full Text via HEAL-Link
|
